https://www.selleckchem.com/pr....oducts/sovilnesib.ht
Tumor collision is a rare entity, which implies failure in the genomic control and replication sites of different cell lines, which, due to their lineage, have different regulatory processes, all this occurring at the same time in the same tissue. The casuistry for collision tumors is scarce; even in the reference centers for oncology, the treatment is challenging given the multiple variables to consider, the particularity of each case, and the scarce evidence on the subject. The casuistry for collision tumors is scarce; even in the
Like
Comment
Share
